731 Costs of care for first-line (1L) treatment of advanced non-small cell lung cancer (aNSCLC): a real-world claims analysis

731 Costs of care for first-line (1L) treatment of advanced non-small cell lung cancer (aNSCLC): a real-world claims analysis

Bibliographic Details
Main Authors: Jonathan Kish, Dhruv Chopra, Djibril Liassou, Solomon Lubinga, John Hartman, Bruce Feinberg
Format: Article
Language:English
Published: BMJ Publishing Group 2020-11-01
Series:Journal for ImmunoTherapy of Cancer
id doaj-24c3218fb66a4baeafcb44ab476db6d7
record_format Article
spelling doaj-24c3218fb66a4baeafcb44ab476db6d72020-12-11T10:03:42ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262020-11-018Suppl 310.1136/jitc-2020-SITC2020.0731731 Costs of care for first-line (1L) treatment of advanced non-small cell lung cancer (aNSCLC): a real-world claims analysisJonathan Kish0Dhruv Chopra1Djibril Liassou2Solomon Lubinga3John Hartman4Bruce Feinberg51Cardinal Health, Dublin, OH, USA1Cardinal Health, Dublin, OH, USA1Cardinal Health, Dublin, OH, USA2Bristol Myers Squibb, Lawrenceville, NJ, USA2Bristol Myers Squibb, Lawrenceville, NJ, USA1Cardinal Health, Dublin, OH, USA
collection DOAJ
language English
format Article
sources DOAJ
author Jonathan Kish
Dhruv Chopra
Djibril Liassou
Solomon Lubinga
John Hartman
Bruce Feinberg
spellingShingle Jonathan Kish
Dhruv Chopra
Djibril Liassou
Solomon Lubinga
John Hartman
Bruce Feinberg
731 Costs of care for first-line (1L) treatment of advanced non-small cell lung cancer (aNSCLC): a real-world claims analysis
Journal for ImmunoTherapy of Cancer
author_facet Jonathan Kish
Dhruv Chopra
Djibril Liassou
Solomon Lubinga
John Hartman
Bruce Feinberg
author_sort Jonathan Kish
title 731 Costs of care for first-line (1L) treatment of advanced non-small cell lung cancer (aNSCLC): a real-world claims analysis
title_short 731 Costs of care for first-line (1L) treatment of advanced non-small cell lung cancer (aNSCLC): a real-world claims analysis
title_full 731 Costs of care for first-line (1L) treatment of advanced non-small cell lung cancer (aNSCLC): a real-world claims analysis
title_fullStr 731 Costs of care for first-line (1L) treatment of advanced non-small cell lung cancer (aNSCLC): a real-world claims analysis
title_full_unstemmed 731 Costs of care for first-line (1L) treatment of advanced non-small cell lung cancer (aNSCLC): a real-world claims analysis
title_sort 731 costs of care for first-line (1l) treatment of advanced non-small cell lung cancer (ansclc): a real-world claims analysis
publisher BMJ Publishing Group
series Journal for ImmunoTherapy of Cancer
issn 2051-1426
publishDate 2020-11-01
work_keys_str_mv AT jonathankish 731costsofcareforfirstline1ltreatmentofadvancednonsmallcelllungcanceransclcarealworldclaimsanalysis
AT dhruvchopra 731costsofcareforfirstline1ltreatmentofadvancednonsmallcelllungcanceransclcarealworldclaimsanalysis
AT djibrilliassou 731costsofcareforfirstline1ltreatmentofadvancednonsmallcelllungcanceransclcarealworldclaimsanalysis
AT solomonlubinga 731costsofcareforfirstline1ltreatmentofadvancednonsmallcelllungcanceransclcarealworldclaimsanalysis
AT johnhartman 731costsofcareforfirstline1ltreatmentofadvancednonsmallcelllungcanceransclcarealworldclaimsanalysis
AT brucefeinberg 731costsofcareforfirstline1ltreatmentofadvancednonsmallcelllungcanceransclcarealworldclaimsanalysis
_version_ 1724386428068036608

Similar Items